Surgery Partners Company Profile (NASDAQ:SGRY)

About Surgery Partners (NASDAQ:SGRY)

Surgery Partners, Inc. is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company's Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services. The Company's surgical facilities primarily provide non-emergency surgical procedures across a range of specialties, which include gastrointestinal (GI), general surgery, ophthalmology, orthopedics and pain management. The Company's Ancillary Services segment consists of a diagnostic laboratory, a specialty pharmacy and multi-specialty physician practices. The Company's physician practices include its owned and operated physician practices pursuant to long-term management service agreements. The Company's Optical Services segment consists of an optical laboratory, an optical products group purchasing organization.

Industry, Sector and Symbol:

Sector: Medical
Industry: Hospitals, Clinics & Primary Care Services
Sub-Industry: N/A
Symbol: NASDAQ:SGRY
CUSIP: N/A
Web: www.surgerypartners.com

Capitalization:

Market Cap: $466.15 million
Outstanding Shares: 48,811,000

Average Prices:

50 Day Moving Avg: $11.70
200 Day Moving Avg: $18.30
52 Week Range: $8.52 - $24.05

P/E:

Trailing P/E Ratio: 64.80
Foreward P/E Ratio: 17.69
P/E Growth: 2.00

Sales & Book Value:

Annual Revenue: $1.13 billion
Price / Sales: 0.41
Book Value: $0.13 per share
Price / Book: 73.46

Profitability:

EBIDTA: $231.39 million
Net Margins: 0.63%
Return on Equity: 6.02%
Return on Assets: 0.81%

Debt:

Debt-to-Equity Ratio: 5.69%
Current Ratio: 1.89%
Quick Ratio: 1.73%

Misc:

Average Volume: 430,859 shs.
Beta: 2.02
Short Ratio: 4.03

Frequently Asked Questions for Surgery Partners (NASDAQ:SGRY)

What is Surgery Partners' stock symbol?

Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."

How were Surgery Partners' earnings last quarter?

Surgery Partners, Inc. (NASDAQ:SGRY) posted its quarterly earnings results on Tuesday, August, 9th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.14 by $0.02. The firm had revenue of $289.70 million for the quarter, compared to analyst estimates of $275.99 million. Surgery Partners had a net margin of 0.63% and a return on equity of 6.02%. The business's revenue for the quarter was up 24.4% on a year-over-year basis. View Surgery Partners' Earnings History.

When will Surgery Partners make its next earnings announcement?

Surgery Partners is scheduled to release their next quarterly earnings announcement on Tuesday, November, 7th 2017. View Earnings Estimates for Surgery Partners.

Where is Surgery Partners' stock going? Where will Surgery Partners' stock price be in 2017?

6 brokerages have issued 12-month price targets for Surgery Partners' shares. Their predictions range from $16.00 to $24.00. On average, they anticipate Surgery Partners' share price to reach $18.80 in the next year. View Analyst Ratings for Surgery Partners.

Who are some of Surgery Partners' key competitors?

Some companies that are related to Surgery Partners include Cardiovascular Systems (CSII), Quality Systems (QSII), Omeros Corporation (OMER), Albany Molecular Research (AMRI), Pharmerica Corporation (PMC), REGENXBIO (RGNX), K2M Group Holdings (KTWO), Editas Medicine (EDIT), Intersect ENT (XENT), Orthofix International N.V. (OFIX), Amarin Corporation PLC (AMRN), Intra-Cellular Therapies (ITCI), Eagle Pharmaceuticals (EGRX), China Cord Blood Corporation (CO), BeyondSpring (BYSI), ZIOPHARM Oncology (ZIOP), Retrophin (RTRX) and Luminex Corporation (LMNX).

Who are Surgery Partners' key executives?

Surgery Partners' management team includes the folowing people:

Michael T. Doyle, Chief Executive Officer, Director
Teresa F. Sparks, Chief Financial Officer, Executive Vice President
John B. Crysel, Group President of Surgery Partners’ National Group
Jennifer Boyd Baldock, Senior Vice President, General Counsel, Secretary
Dennis Dean, Senior Vice President, Corporate Controller
Teresa DeLuca M.D., Director
Adam Feinstein, Independent Director
Brent Turner, Independent Director

Who owns Surgery Partners stock?

Surgery Partners' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include FMR LLC (5.29%), TimesSquare Capital Management LLC (3.33%), Vanguard Group Inc. (3.27%), Neuberger Berman Group LLC (3.10%), NN Investment Partners Holdings N.V. (2.50%) and Peregrine Capital Management LLC (1.85%). Company insiders that own Surgery Partners stock include HIG Surgery Centers, Llc, Jennifer Baldock and Michael Thomas Doyle. View Institutional Ownership Trends for Surgery Partners.

Who sold Surgery Partners stock? Who is selling Surgery Partners stock?

Surgery Partners' stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, TimesSquare Capital Management LLC, Jennison Associates LLC, Eagle Asset Management Inc., Marshall Wace North America L.P., Neuberger Berman Group LLC, JPMorgan Chase & Co. and Macquarie Group Ltd.. View Insider Buying and Selling for Surgery Partners.

Who bought Surgery Partners stock? Who is buying Surgery Partners stock?

Surgery Partners' stock was bought by a variety of institutional investors in the last quarter, including Elk Creek Partners LLC, NN Investment Partners Holdings N.V., Dimensional Fund Advisors LP, Royce & Associates LP, AMI Asset Management Corp, Wells Fargo & Company MN, JHL Capital Group LLC and First Trust Advisors LP. View Insider Buying and Selling for Surgery Partners.

How do I buy Surgery Partners stock?

Shares of Surgery Partners can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Surgery Partners' stock price today?

One share of Surgery Partners stock can currently be purchased for approximately $9.55.

MarketBeat Community Rating for Surgery Partners (NASDAQ SGRY)

Community Ranking:		2.4 out of 5 ( )
Outperform Votes:		83 (Vote Outperform)
Underperform Votes:		87 (Vote Underperform)
Total Votes:		170

MarketBeat's community ratings are surveys of what our community members think about Surgery Partners and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Consensus Ratings for Surgery Partners (NASDAQ:SGRY) (How are Consensus Ratings Calculated?)

Ratings Breakdown:	1 Sell Rating, 1 Hold Rating, 4 Buy Ratings
Consensus Rating:	Buy (Score: 2.50)
Consensus Price Target:	$18.80 (96.86% upside)

Analysts' Ratings History for Surgery Partners (NASDAQ:SGRY)

Show:

Date	Firm	Action	Rating	Price Target	Impact on Share Price
9/8/2017	Jefferies Group LLC	Reiterated Rating	Buy	$22.00 -> $16.00	Low
8/11/2017	Citigroup Inc.	Reiterated Rating	Buy	$28.00 -> $17.00	Low
8/9/2017	Raymond James Financial, Inc.	Reiterated Rating	Strong-Buy -> Market Perform		High
8/9/2017	Stifel Nicolaus	Downgrade	Hold -> Sell	$21.00 -> $17.00	High
1/31/2017	Benchmark Co.	Initiated Coverage	Buy	$24.00	N/A
1/3/2017	Royal Bank of Canada	Reiterated Rating	Buy	$20.00	N/A
7/13/2016	Barclays PLC	Initiated Coverage	Equal Weight	$20.00	N/A
6/9/2016	KeyCorp	Initiated Coverage	Overweight	$21.00	N/A
5/6/2016	Morgan Stanley	Reiterated Rating	Hold		N/A
3/14/2016	Goldman Sachs Group, Inc. (The)	Lower Price Target		$23.00 -> $20.00	N/A
10/26/2015	Bank of America Corporation	Initiated Coverage	Buy	$27.00	N/A

(Data available from 9/20/2015 forward)

Earnings History for Surgery Partners (NASDAQ:SGRY)

Earnings by Quarter for Surgery Partners (NASDAQ:SGRY)

Earnings History by Quarter for Surgery Partners (NASDAQ SGRY)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/7/2017		$0.03					N/A
3/9/2017	Q4 2016	$0.20	$0.19	$298.16 million	$306.00 million	View	Listen
11/9/2016	Q3 2016	$0.14	$0.21	$283.80 million	$282.70 million	View	Listen
8/9/2016	Q216	$0.14	$0.16	$275.99 million	$289.70 million	View	Listen
5/5/2016	Q116	$0.03	($0.15)	$255.06 million	$267.10 million	View	N/A
3/10/2016	Q415	$0.19	$0.35	$246.70 million	$263.00 million	View	Listen
11/12/2015	Q315	$0.01	$0.04	$234.58 million	$239.60 million	View	Listen

(Data available from 1/1/2011 forward)

Earnings Estimates for Surgery Partners (NASDAQ:SGRY)

2017 EPS Consensus Estimate: $0.71

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2017	2	$0.09	$0.10	$0.10
Q2 2017	2	$0.20	$0.20	$0.20
Q3 2017	2	$0.03	$0.19	$0.11
Q4 2017	2	$0.24	$0.37	$0.31

(Data provided by Zacks Investment Research)

Dividend History for Surgery Partners (NASDAQ:SGRY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading and Institutional Ownership History for Surgery Partners (NASDAQ:SGRY)

Insider Ownership Percentage: 7.50%
Institutional Ownership Percentage: 38.06%

Institutional Ownership by Quarter for Surgery Partners (NASDAQ:SGRY)

Insider Trades by Quarter for Surgery Partners (NASDAQ:SGRY)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
8/31/2017	H.I.G. Surgery Centers, Llc	Major Shareholder	Sell	26,455,651	$19.00	$502,657,369.00
8/29/2016	Jennifer Baldock	VP	Sell	2,500	$19.20	$48,000.00
10/21/2015	H.I.G. Surgery Centers, Llc	Major Shareholder	Sell	1,324,464	$19.00	$25,164,816.00
10/21/2015	Michael Thomas Doyle	CEO	Sell	152,966	$19.00	$2,906,354.00

(Data available from 1/1/2013 forward)

Headline Trends for Surgery Partners (NASDAQ:SGRY) Latest Headlines for Surgery Partners (NASDAQ:SGRY)

Source:

Date	Headline
	Surgery Partners, Inc. (SGRY) Given Consensus Rating of "Hold" by Analysts www.americanbankingnews.com - September 17 at 5:02 AM
	Comparing Surgery Partners (SGRY) & Premier (PINC) www.americanbankingnews.com - September 16 at 6:36 AM
	$312.81 Million in Sales Expected for Surgery Partners, Inc. (SGRY) This Quarter www.americanbankingnews.com - September 14 at 8:20 AM
	Surgery Partners Is Now Oversold (SGRY) www.thestreet.com - September 9 at 8:30 AM
	Surgery Partners Is Now Oversold (SGRY) www.thestreet.com - September 9 at 8:30 AM
	CEO out at Nashville health care company finance.yahoo.com - September 9 at 8:29 AM
	CEO out at Nashville health care company finance.yahoo.com - September 9 at 8:29 AM
	Jefferies Group LLC Reiterates "Buy" Rating for Surgery Partners, Inc. (SGRY) www.americanbankingnews.com - September 9 at 12:32 AM
	Surgery Partners Announces Appointment of Clifford Adlerz as Interim Chief Executive Officer finance.yahoo.com - September 8 at 8:17 AM
	Surgery Partners, Inc. (SGRY) Major Shareholder Sells $502,657,369.00 in Stock www.americanbankingnews.com - September 5 at 4:26 PM
	Surgery Partners Completes Acquisition of National Surgical Healthcare finance.yahoo.com - September 1 at 8:36 AM
	U.S. Physical Therapy (USPH) vs. Surgery Partners (SGRY) Head to Head Survey www.americanbankingnews.com - August 27 at 10:28 AM
	$309.87 Million in Sales Expected for Surgery Partners, Inc. (SGRY) This Quarter www.americanbankingnews.com - August 26 at 1:30 AM
	Analysts Expect Surgery Partners, Inc. (SGRY) to Post $0.03 Earnings Per Share www.americanbankingnews.com - August 24 at 8:32 PM
	Surgery Partners, Inc. (SGRY) Receives Average Rating of "Hold" from Brokerages www.americanbankingnews.com - August 23 at 5:06 AM
	AAC Holdings (AAC) versus Surgery Partners (SGRY) Head-To-Head Review www.americanbankingnews.com - August 18 at 10:46 AM
	Surgery Partners, Inc. (SGRY) Downgraded by Zacks Investment Research to Strong Sell www.americanbankingnews.com - August 12 at 6:36 AM
	Surgery Partners, Inc. (SGRY) Price Target Lowered to $17.00 at Citigroup Inc. www.americanbankingnews.com - August 11 at 6:20 PM
	Surgery Partners, Inc. Expected to Earn Q3 2017 Earnings of $0.03 Per Share (NASDAQ:SGRY) www.americanbankingnews.com - August 11 at 11:40 AM
	Surgery Partners Stock Plummets After Q2 Results Hint At Integration Challenges finance.yahoo.com - August 11 at 8:28 AM
	Surgery Partners Takes Lumps on Q2 Figures www.baystreet.ca - August 10 at 7:48 AM
	Surgery Partners, Inc. (SGRY) Misses Q2 EPS by 27c, Miss on Revenues; Offers FY17 Revenues www.streetinsider.com - August 10 at 7:48 AM
	Surgery Partners' (SGRY) CEO Brett Roberts on Q2 2017 Results - Earnings Call Transcript www.msn.com - August 10 at 7:48 AM
	Edited Transcript of SGRY earnings conference call or presentation 9-Aug-17 12:30pm GMT finance.yahoo.com - August 10 at 7:48 AM
	Here's Why Surgery Partners Inc. Is Sinking Today finance.yahoo.com - August 10 at 7:48 AM
	Surgery Partners, Inc. (NASDAQ:SGRY) Stock Rating Reaffirmed by Raymond James Financial, Inc. www.americanbankingnews.com - August 9 at 9:00 AM
	Surgery Partners, Inc. Announces Second Quarter 2017 Results finance.yahoo.com - August 9 at 7:26 AM
	Surgery Partners, Inc. (NASDAQ:SGRY) Expected to Post Quarterly Sales of $317.06 Million www.americanbankingnews.com - August 8 at 7:44 AM
	$0.18 EPS Expected for Surgery Partners, Inc. (NASDAQ:SGRY) This Quarter www.americanbankingnews.com - August 6 at 12:28 PM
	Surgery Partners, Inc. (NASDAQ:SGRY) Cut to "Strong Sell" at BidaskClub www.americanbankingnews.com - August 5 at 5:30 PM
	Critical Contrast: AAC Holdings (AAC) and Surgery Partners (SGRY) www.americanbankingnews.com - August 3 at 2:44 PM
	AAC Holdings (AAC) & Surgery Partners (SGRY) Financial Comparison www.americanbankingnews.com - August 2 at 8:22 PM
	Surgery Partners, Inc. (NASDAQ:SGRY) Rating Increased to Buy at Zacks Investment Research www.americanbankingnews.com - August 2 at 8:32 AM
	Surgery Partners, Inc. (SGRY) to Release Quarterly Earnings on Monday www.americanbankingnews.com - July 31 at 8:30 AM
	Comparing Surgery Partners (SGRY) and Quorum Health Corporation (QHC) www.americanbankingnews.com - July 31 at 12:35 AM
	Surgery Partners, Inc. (NASDAQ:SGRY) Given Average Recommendation of "Hold" by Brokerages www.americanbankingnews.com - July 29 at 7:45 AM
	BioScrip (BIOS) vs. Surgery Partners (NASDAQ:SGRY) Financial Review www.americanbankingnews.com - July 27 at 9:36 AM
	Surgery Partners, Inc. Announces Second Quarter 2017 Earnings Release Date and Conference Call Details finance.yahoo.com - July 26 at 7:21 AM
	BidaskClub Lowers Surgery Partners, Inc. (SGRY) to Sell www.americanbankingnews.com - July 24 at 7:52 PM
	Comparing Surgery Partners (NASDAQ:SGRY) and AAC Holdings (AAC) www.americanbankingnews.com - July 21 at 4:36 PM
	Surgery Partners, Inc. (NASDAQ:SGRY) Expected to Announce Quarterly Sales of $317.06 Million www.americanbankingnews.com - July 19 at 3:02 PM
	Surgery Partners Investigation By Block & Leviton LLP finance.yahoo.com - July 18 at 8:07 AM
	$0.17 EPS Expected for Surgery Partners, Inc. (NASDAQ:SGRY) This Quarter www.americanbankingnews.com - July 17 at 11:29 AM
	Critical Comparison: Healthways (TVTY) versus Surgery Partners (NASDAQ:SGRY) www.americanbankingnews.com - July 16 at 12:26 PM
	Surgery Partners, Inc. – Value Analysis (NASDAQ:SGRY) : July 10, 2017 finance.yahoo.com - July 11 at 7:36 AM
	Surgery Partners, Inc. breached its 50 day moving average in a Bearish Manner : SGRY-US : July 7, 2017 finance.yahoo.com - July 7 at 11:14 AM
	Surgery Partners, Inc. (NASDAQ:SGRY) Given Average Rating of "Hold" by Analysts www.americanbankingnews.com - July 4 at 11:29 AM
	Zacks: Brokerages Expect Surgery Partners, Inc. (SGRY) Will Post Quarterly Sales of $317.06 Million www.americanbankingnews.com - June 23 at 5:52 PM
	Surgery Partners, Inc. (SGRY) Raised to "Buy" at BidaskClub www.americanbankingnews.com - June 21 at 3:40 PM
	Brokerages Expect Surgery Partners, Inc. (SGRY) Will Announce Earnings of $0.18 Per Share www.americanbankingnews.com - June 21 at 7:34 AM